Flecainide µ¶¼º°ú °ü·ÃµÈ Ä¡¸íÀûÀÎ ½É½Ç»óºó¸ÆÀÇ 1¿¹
A Case of Life-Threatening Supraventricular Tachycardia Related to Flecainide Toxicity
´ëÇѳ»°úÇÐȸÁö 2014³â 87±Ç 1È£ p.72 ~ p.76
õ»ó¼ö(Cheon Sang-Soo) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
¼ÛÁØÇõ(Song Joon-Hyuk) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
¹è¸íȯ(Bae Myung-Hwan) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
ÀÌÀåÈÆ(Lee Jang-Hoon) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
¾çµ¿Çå(Yang Dong-Heon) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
¹ÚÈƽÄ(Park Hun-Sik) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
伺ö(Chae Shung-Chul) - °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç ¼øȯ±â³»°ú
Abstract
Flecainide acetate is a potent class Ic anti-arrhythmic drug with a major sodium channel-blocking effect. Flecainide toxicity can cause myocardial impairment and precipitate circulatory collapse, particularly in patients with renal failure. Electrical and hemodynamic deterioration during flecainide toxicity may not respond to conventional treatments. We report the successful management of flecainide toxicity using extracorporeal membrane oxygenation (ECMO), hemoperfusion, and bicarbonate administration maintaining alkalinity.
Å°¿öµå
Flecainide, Hemoperfusion, Extracorporeal membrane oxygenation
KMID :
0882420140870010072
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)